Validity and Reliability of the 12-item Multiple Sclerosis Walking Scale (12-WS) in Subjects With Spinal Cord Injury (12-WS SCI)

University of Zurich (UZH)

Status

Completed

Conditions

Spinal Cord Injuries

Gait Disorders, Neurologic

Treatments

Other: 12 MSWS questionnaire

Study type

Interventional

Funder types

Other

NETWORK

Identifiers

NCT06256159

2023-02304

Details and patient eligibility

About

Established gait assessments for subjects with spinal cord injury (SCI) (6MWT, 10MWT, TUG, SCIM III and WISCI II) are widely used in the clinical and research setting. So far, no valid measurement exists that assesses the patients' perspective of walking ability in SCI. As there is the 12-item Multiple Sclerosis Walking Scale (12-WS) to assess the patients' perspective on gait ability in patients with multiple sclerosis, it is hypothesized that the 12-WS would also be a valid instrument for subjects with incomplete SCI. The main goal of this study is to collect data from clinical gait assessments in subjects with spinal lesions and to demonstrate that the 12-WS is a valid and reliable patient-reported outcome measurement for individuals with incomplete spinal cord injury.

Enrollment

67 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Age 18-80 years
Diagnosis of chronic spinal cord injury (>6 months; cervical or thoracic motor incomplete traumatic or non-traumatic (AIS C, D) above T12
Must have impaired walking function as demonstrated by neurological examination.

Exclusion criteria

Women who are pregnant or breast feeding
Current orthopaedic problems of lower limbs
History of major cardiac condition (e.g., infarction, insufficiency (NYHA II-IV))
History of major pulmonary condition (e.g., chronic obstructive pulmonary disease GOLD II-IV
Current major depression or psychosis
Participation in another interventional study (except specTra-study) that may have an impact on walking function.